Reporting of conflicts of interest from drug trials in Cochrane reviews: cross sectional study

scientific article

Reporting of conflicts of interest from drug trials in Cochrane reviews: cross sectional study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1136/BMJ.E5155
P932PMC publication ID3423635
P698PubMed publication ID22906823
P5875ResearchGate publication ID230711265

P50authorLisa BeroQ16192607
Brett D ThombsQ42350951
Erick H TurnerQ58325540
Joel LexchinQ88126817
Michelle RosemanQ125215088
P2093author name stringJames C Coyne
P2860cites workEpidemiology and reporting characteristics of systematic reviewsQ21144675
Factors associated with findings of published trials of drug-drug comparisons: why some statins appear more efficacious than othersQ21563421
Selective Publication of Antidepressant Trials and Its Influence on Apparent EfficacyQ23791313
Partisan perspectives in the medical literature: a study of high frequency editorialists favoring hormone replacement therapyQ24289488
CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trialsQ24614627
Pharmaceutical industry sponsorship and research outcome and quality: systematic reviewQ24673248
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaborationQ27860581
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statementQ27860868
Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentationQ28474127
Factors associated with results and conclusions of trials of thiazolidinedionesQ28475588
Scope and impact of financial conflicts of interest in biomedical research: a systematic reviewQ29616086
Association between competing interests and authors' conclusions: epidemiological study of randomised clinical trials published in the BMJQ33960572
Those who have the gold make the evidence: how the pharmaceutical industry biases the outcomes of clinical trials of medicationsQ34025773
Association between industry affiliation and position on cardiovascular risk with rosiglitazone: cross sectional systematic reviewQ34105156
Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatmentsQ34169330
A new system for grading recommendations in evidence based guidelinesQ34332845
Evidence b(i)ased medicine--selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applicationsQ34534086
The reporting quality of meta-analyses improves: a random sampling studyQ34769829
Cochrane reviews compared with industry supported meta-analyses and other meta-analyses of the same drugs: systematic reviewQ35082900
Assessment of methodological quality of primary studies by systematic reviews: results of the metaquality cross sectional studyQ36092201
Relative citation impact of various study designs in the health sciencesQ36130841
Financial ties and concordance between results and conclusions in meta-analyses: retrospective cohort studyQ36248519
Pharmaceutical company funding and its consequences: a qualitative systematic reviewQ36962660
Does the type of competing interest statement affect readers' perceptions of the credibility of research? Randomised trialQ37268456
The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviewsQ37692721
The impact of disclosing financial ties in research and clinical care: a systematic reviewQ37737486
Does declaration of competing interests affect readers' perceptions? A randomised trialQ39691480
Systems to rate the strength of scientific evidenceQ40643928
CONSORT for reporting randomised trials in journal and conference abstractsQ56880300
Toward More Uniform Conflict DisclosuresQ57247850
The quality of drug studies published in symposium proceedingsQ71004282
How pharmaceutical industry funding affects trial outcomes: causal structures and responsesQ80770643
It's time to rebuild the evidence baseQ84196688
P407language of work or nameEnglishQ1860
P304page(s)e5155
P577publication date2012-08-16
P1433published inThe BMJQ546003
P1476titleReporting of conflicts of interest from drug trials in Cochrane reviews: cross sectional study
P478volume345

Reverse relations

cites work (P2860)
Q34794434Association of industry sponsorship and positive outcome in randomised controlled trials in general and abdominal surgery: protocol for a systematic review and empirical study
Q24658631Conflict of interest disclosure in biomedical research: a review of current practices, biases, and the role of public registries in improving transparency
Q34523783Conflicts of interest and spin in reviews of psychological therapies: a systematic review
Q37487299Conflicts of interest in biomedical publications: considerations for authors, peer reviewers, and editors.
Q36391292Conflicts of interest in nutritional sciences: The forgotten bias in meta-analysis
Q36585408Depression screening and mental health outcomes in children and adolescents: a systematic review protocol
Q24289431Effects of screening for psychological distress on patient outcomes in cancer: a systematic review
Q36887082Evaluation of the Cochrane tool for assessing risk of bias in randomized clinical trials: overview of published comments and analysis of user practice in Cochrane and non-Cochrane reviews
Q36951441Financial Relationships between Organizations That Produce Clinical Practice Guidelines and the Biomedical Industry: A Cross-Sectional Study
Q60603546Has Cochrane lost its way?
Q38193904Has industry funding biased studies of the protective effects of alcohol on cardiovascular disease? A preliminary investigation of prospective cohort studies
Q36920494Industry influence in evidence production
Q24202591Industry sponsorship and research outcome
Q38186856Methodological quality of systematic reviews on influenza vaccination
Q36263109Potential Conflict of Interest and Bias in the RACGP's Smoking Cessation Guidelines: Are GPs Provided with the Best Advice on Smoking Cessation for their Patients?
Q91736607Reporting of financial conflicts of interest in meta-analyses of drug trials published in high-impact medical journals: comparison of results from 2017 to 2018 and 2009
Q47626625Scientism, conflicts of interest, and the marginalization of ethics in medical education.
Q54373404Study sponsorship and the nutrition research agenda: analysis of randomized controlled trials included in systematic reviews of nutrition interventions to address obesity.
Q24289237The cycle of bias in health research: a framework and toolbox for critical appraisal training
Q38141169The evolution of assessing bias in Cochrane systematic reviews of interventions: celebrating methodological contributions of the Cochrane Collaboration
Q24201550Why the Cochrane Risk of Bias Tool Should Include Funding Source as a Standard Item

Search more.